CAPR CAPRICOR THERAPEUTICS INC revenue, earnings and financials
For the quarter ended June 30, 2026, CAPRICOR THERAPEUTICS INC reported revenue of n/a, net income of −$40.7M and diluted EPS of −$0.70; for the fiscal year ended December 2025 revenue was $0, down 100.0% on the year before.
CAPR annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $0, gross profit n/a, operating income −$108M, net income −$105M (margin n/a), EPS −$2.26
- Fiscal year ended Dec 2024: revenue $22.3M, gross profit n/a, operating income −$42.6M, net income −$40.5M (margin -181.7%), EPS −$1.15
- Fiscal year ended Dec 2023: revenue $25.2M, gross profit n/a, operating income −$24.1M, net income −$22.3M (margin -88.5%), EPS −$0.83
- Fiscal year ended Dec 2022: revenue $2.55M, gross profit n/a, operating income −$29.7M, net income −$29.0M (margin -1137.4%), EPS −$1.18
- Fiscal year ended Dec 2021: revenue $245K, gross profit n/a, operating income −$20.9M, net income −$20.0M (margin -8175.9%), EPS −$0.87
CAPR quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$40.7M, EPS −$0.70
- Quarter ended Mar 31, 2026: revenue n/a, net income −$33.9M, EPS −$0.59
- Quarter ended Dec 31, 2025 (from the annual report): revenue n/a, net income −$30.2M, EPS −$0.62
- Quarter ended Sep 30, 2025: revenue n/a, net income −$24.6M, EPS −$0.54
- Quarter ended Jun 30, 2025: revenue n/a, net income −$25.9M, EPS −$0.57
- Quarter ended Mar 31, 2025: revenue n/a, net income −$24.4M, EPS −$0.53
- Quarter ended Dec 31, 2024 (from the annual report): revenue $11.1M (down 7.9% year over year), net income −$7.12M, EPS −$0.11
- Quarter ended Sep 30, 2024: revenue $2.26M (down 63.4% year over year), net income −$12.6M, EPS −$0.38
- Quarter ended Jun 30, 2024: revenue $3.97M (up 1.4% year over year), net income −$11.0M, EPS −$0.35
- Quarter ended Mar 31, 2024: revenue $4.91M (up 64.3% year over year), net income −$9.79M, EPS −$0.31
- Quarter ended Dec 31, 2023 (from the annual report): revenue $12.1M, net income −$762K, EPS $0.02
- Quarter ended Sep 30, 2023: revenue $6.19M (up 288.7% year over year), net income −$6.39M, EPS −$0.25
- Quarter ended Jun 30, 2023: revenue $3.92M, net income −$7.37M, EPS −$0.29
- Quarter ended Mar 31, 2023: revenue $2.99M, net income −$7.77M, EPS −$0.31
- Quarter ended Dec 31, 2022 (from the annual report): revenue n/a, net income −$7.72M, EPS −$0.31
- Quarter ended Sep 30, 2022: revenue $1.59M, net income −$6.37M, EPS −$0.26
- Quarter ended Jun 30, 2022: revenue n/a, net income −$7.11M, EPS −$0.29
- Quarter ended Mar 31, 2022: revenue n/a, net income −$7.82M, EPS −$0.32
- Quarter ended Dec 31, 2021 (from the annual report): revenue n/a, net income −$6.19M, EPS −$0.26
- Quarter ended Sep 30, 2021: revenue n/a, net income −$3.93M, EPS −$0.17
CAPR cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$69.8M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$40.0M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$25.6M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow $4.92M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$16.8M, share buybacks n/a
CAPR balance sheet
- Jun 30, 2026: cash $20.9M, total assets $369M, total liabilities $123M, shareholders' equity $246M
- Mar 31, 2026: cash $105M, total assets $326M, total liabilities $47.6M, shareholders' equity $279M
- Dec 31, 2025: cash $288M, total assets $356M, total liabilities $50.2M, shareholders' equity $306M
- Sep 30, 2025: cash $19.5M, total assets $126M, total liabilities $42.6M, shareholders' equity $83.9M
- Jun 30, 2025: cash $23.2M, total assets $134M, total liabilities $28.6M, shareholders' equity $105M
- Mar 31, 2025: cash $28.8M, total assets $154M, total liabilities $26.1M, shareholders' equity $128M
- Dec 31, 2024: cash $11.3M, total assets $170M, total liabilities $25.0M, shareholders' equity $145M
- Sep 30, 2024: cash $68.4M, total assets $93.0M, total liabilities $24.7M, shareholders' equity $68.3M
What is CAPR's revenue?
CAPRICOR THERAPEUTICS INC reported $0 of revenue for the fiscal year ended December 2025.
Is CAPR profitable?
No. CAPRICOR THERAPEUTICS INC lost $129M over the last four quarters.
What is CAPR's EPS?
Diluted earnings per share over the last four quarters were −$2.45; −$0.70 in the latest quarter.